EpigenDx was incorporated in 2006 as a genomic and epigenomic research company specializing in disease biomarker discovery, validation and molecular diagnosis, with an unmatched expertise in the field of DNA methylation analysis.
EpigenDx provides superior products and laboratory services for scientific researchers from academic, government and industrial communities from all over the world. Our commitment to quality reflects our desire and dedication to provide the best products and services to our customers. EpigenDx has extensive knowledge and expertise in Pyrosequencing, bisulfite sequencing, and various epigenomic research analysis techniques and methods stemming from our years of experience in the industry.
EpigenDx Lab Services include:
- Bisulfite Pyrosequencing: determine loci specific methylation and global methylation levels individual CpGs sites
- Targeted MethylSeq: determine methylation levels in multiple targeted regions at base pair resolution
- Gene and miRNA profiling using Affymetrix Gene Chip arrays
Mutation & SNP Analysis
- Quantative mutation analysis using Pyrosequencing for minor allele detection, allele specific expression
- 1.8 million SNPs and copy number changes using Affymetrix 6.0 Array
EpigenDx products include:
DNA Methylation Controls: low and high methylated genomic DNA for studying human, mouse, rat genes
Validated loci specific DNA methylation assays for multiple platforms including bisulfite sequencing, bisulfite Pyrosequencing, and realtime based PCR analysis. All assays are validated for PCR bias or preferential amplification.
Methylation Panels including Stem Cell Panel, Cancer Panel, Immunology Panel, and CNS Panel. They are designed for bisulfite sequencing analysis using either Pyrosequencing or NGS platforms.
Multispan, Inc. is a premier assay screening technology provider targeting GPCRs, kinases and beyond using endogenously expressed targets in primary cells and recombinant stable cell lines. It has created the industry’s largest, highly characterized, highest quality GPCR-expressing stable cell lines and assays based on cell signaling and phenotypic biology. Multispan offers integrated high quality solutions in assay development, HTS and SAR lead optimization screening support to shorten time to IND and discover better medicine in cardiovascular, metabolic, CNS, inflammation, immunology and oncology diseases. Multispan’s high standard of quality and integrity has earned successful long-term collaborations with a wide range of leading pharmaceutical and biotech companies globally.
Allphase Clinical Research is a full-service clinical development company providing clinical trial management services, including regulatory affairs, project management, clinical monitoring, data management, quality assurance auditing, drug safety, and medical writing. Allphase provides Phase I to IV support throughout a wide range of therapeutic areas, with a predominant focus in oncology, CNS, and critical care diseases.
Allphase provides integrative and strategic clinical trial services that allow our international partners to realize the advantages of conducting clinical trails in North America, while reinforcing therir global development cpabilities.
Amarex is a global, full-service Contract Research Organization (CRO), whose leadership team has significant expertise conducting biomedical research, and whose combined experience includes the design and conduct of several hundred clinical research projects in many therapeutic indications. Amarex provides comprehensive services in Project Management (Phase I-IV, BE/BA, PK/PD), Regulatory Affairs (FDA Applications and meetings, Applications to International Health Authorities, GxP Compliance Audits), Clinical Operations, Adaptive Study Designs, Statistical Analysis, Data Management, Medical Monitoring, Safety and Pharmacovigilance, and General Consulting. Amarex can take your product through the entire approval process, from creating the regulatory approval strategy, to conducting trials, to writing the marketing approval application. Join our growing list of clients with approved products. Amarex provides high quality and cost efficient services.
Sign-up to receive invites to webinars, training courses and the latest cutting-edge information on clinical trials: https://go.pardot.com/l/129231/2020-07-27/39ng9k
ChemDiv, a fully Integrated Target-to-Market Contract Research Organization (CRO) headquartered in San Diego, CA USA.
ChemDiv provides integrated drug discovery and early clinical development deliverables by extracting added value from potential therapeutic candidates via rapid, streamlined outcomes and effective use of capital.
- 25 years experience and 2500 customers worldwide
- Premium R&D CRO based in USA with global reach
- Seasoned project managers
- Extensive Academic partnerships
- Flexible business models
- Competitive pricing options
- Industry's largest ever-greening stock compound inventory
- Ongoing investments in novel proprietary chemistry and discovery platforms
One of the oldest CROs in the industry, ChemDiv provides Integrated Discovery outSource™ solutions that cover the complete range of disciplines needed to bring new drugs for treatment of CNS, oncology, inflammation, metabolic and infectious diseases from target to candidate and through clinical Proof of Concept to the market. ChemDiv champions collaborative development models with co-investors to rescue under-exploited R&D assets for pharmaceutical and biotech partners.